Communities First is a non profit that helps communities through economic development, affordable housing and innovative programming.
Kenosha Community Health Center provides medical services and rehabilitation. Their medical services include serving children from birth to adolescence, providing immunizations, screenings, and regular well-child checkups, including preventative exams and education for parents. They provide behavioral screenings and interventions, chronic disease management, and care coordination. They provide dental services that include general dentistry, fillings, root canals, and much more. In addition, they provide pharmacy services.
Advocates for Community Wellness is a faith-based health promotion and disease prevention ministry without walls and is a nonprofit local community organization.
Kaleida Health is a hospital and physicians network in Western New York.
The company primarily operates in the Clinics/Outpatient Services industry. Erie Family Health Center was founded in 1991 and is headquartered in Chicago, IL. Similar Companies include Near North Health Service and University of Illinois Hospital and Health Sciences System.
Mark Masselli, along with a small group of Wesleyan University students and community activists, founded Community Health Center. Mark also has played an important leadership role as a founding member of many health and human services initiatives
AltaMed has delivered quality care to the underserved communities of Southern California for more than 40 years.AltaMed has delivered quality care to the underserved communities of Southern California for more than 40 years. Accredited by the Joint Commission, AltaMed prides itself in the quality of its care delivered by its premier health care professionals.
R.L. Jones Community Outreach Center focuses on assisting those in need.
Angeles Community Health Center offers primary medical care, dental services, and care coordination. They are committed to providing care in accordance with the "Patient Centered Medical Home" concept. When they choose and receive primary medical care from an ACHC provider, the ACHC becomes their medical home.
Developer of breast cancer radiotherapy tests intended to identify which women with early-stage invasive breast cancer truly need radiation therapy. The company's tests indicate if the radiation therapy can benefit the patient, enabling doctors to personalize the treatment of breast cancer patients, improve outcomes and reduce unnecessary treatment.
Ashion Analytics is a clinical genomics testing company focused on enhancing the application of genomic data to support healthcare providers in delivering tailored treatment options for patients. The company operates a laboratory that addresses the complex needs of clinical, academic, and biopharma clients by offering a range of services, including large panel tests, whole exome sequencing, RNA sequencing, and support for research and drug development. Through its commitment to personalized medicine and data analytics, Ashion Analytics aims to improve patient outcomes by ensuring that healthcare providers have access to the necessary genomic information to make informed treatment decisions.
Thrive Earlier Detection Corp. is a healthcare company dedicated to improving cancer detection through innovative technology. It focuses on the development of CancerSEEK, a liquid biopsy test that analyzes genomic mutations in tumor DNA and protein markers in plasma to identify multiple types of cancer at their earliest stages, often before symptoms become apparent. Founded in 2018 and headquartered in Cambridge, Massachusetts, with an additional office in Baltimore, Maryland, Thrive aims to integrate early cancer detection into routine medical care. The company was previously known as Thrive Sciences Inc. and has been a subsidiary of Exact Sciences Corporation since early 2021. Thrive was launched with support from various investors, including Third Rock Ventures and Section 32, reflecting a strong commitment to advancing cancer diagnostics.
Base Genomics Limited is an epigenetics company focused on advancing DNA methylation technology through its innovative TAPS (TET-assisted pyridine borane sequencing) method. Developed at the Ludwig Institute for Cancer Research at the University of Oxford, TAPS allows for the simultaneous generation of genetic and epigenetic information at base resolution. This technology addresses the limitations of traditional bisulfite sequencing by preserving DNA integrity, thus providing more high-quality data from smaller samples. Base Genomics targets various significant markets, including early cancer detection, minimal residual disease analysis, patient monitoring, and non-invasive prenatal testing. The company aims to enhance medical practices by offering reliable and efficient methods for cancer detection and monitoring, ultimately transforming patient outcomes. Base Genomics was founded in 2019 and is based in Oxford, United Kingdom.
Viomics Inc. develops and delivers cancer detection technologies to enable early and targeted intervention that cures previously deadly cancers. Viomics Inc. was founded in 2012 and is based in Phoenix, Arizona. As of March 3, 2020, Viomics Inc. operates as a subsidiary of Exact Sciences Corporation.
Paradigm Diagnostics specializes in advanced cancer diagnostics and biomarker-driven clinical trials, aiming to enhance treatment options for cancer patients. Utilizing next-generation sequencing and comprehensive biomarker analysis, Paradigm assesses the genomic and proteomic characteristics of individual tumors. This information allows for a detailed understanding of the specific cancer pathways involved and the potential therapies tailored to each patient's unique tumor profile. By focusing on personalized medicine, Paradigm empowers healthcare providers to offer targeted treatment strategies, ultimately improving patient outcomes in cancer care.
Genomic Health is a provider of genomic-based diagnostic tests focused on improving the treatment of early-stage cancer, aiming to reduce both overtreatment and undertreatment in healthcare. The company leverages its scientific and commercial expertise to translate extensive genomic data into clinically actionable insights, facilitating effective treatment planning for cancer patients from diagnosis through treatment selection and monitoring. Headquartered in Redwood City, California, Genomic Health also has a European office in Geneva, Switzerland, positioning itself as a leader in the application of genomic information to enhance cancer care.
Thrive Earlier Detection Corp. is a healthcare company dedicated to improving cancer detection through innovative technology. It focuses on the development of CancerSEEK, a liquid biopsy test that analyzes genomic mutations in tumor DNA and protein markers in plasma to identify multiple types of cancer at their earliest stages, often before symptoms become apparent. Founded in 2018 and headquartered in Cambridge, Massachusetts, with an additional office in Baltimore, Maryland, Thrive aims to integrate early cancer detection into routine medical care. The company was previously known as Thrive Sciences Inc. and has been a subsidiary of Exact Sciences Corporation since early 2021. Thrive was launched with support from various investors, including Third Rock Ventures and Section 32, reflecting a strong commitment to advancing cancer diagnostics.
Biomatrica (www.biomatrica.com) is a San Diego-based biostability company that provides innovative technologies for stabilizing, processing, storing and shipping biological samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis (“life without waterâ€), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA, RNA, proteins, cells and assays with no sample degradation, allowing scientists and clinicians to have pristine samples and reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories. Custom services to stabilize additional sample types are also available. Biomatrica also offers SampleWare® software, an easy-to-use, customizable laboratory management database that provides scientists with the means to store and organize their sample data, and directly supports samples stabilized by Biomatrica technology. For more information about the SampleMatrix technology and the Biomatrica products utilizing this technology platform (DNAstable®, DNAstable Blood, DNAgard Tissue and DNAgard Blood for DNA, RNAstable® and RNAconcentrator for RNA, and CloneStable® for bacterial DNA),
Armune BioScience, Inc. is a medical diagnostics company based in Kalamazoo, Michigan, focused on developing and commercializing blood tests that utilize the immune system's responses to detect cancer early. Founded in 2007 by members of the Apjohn Group, the company specializes in diagnostic and prognostic tests for prostate, lung, and breast cancers, facilitating personalized treatment decisions for patients and physicians. Its flagship product, APIFINY, is a cancer-specific blood test that assesses the risk of prostate cancer by measuring immune-related biological markers, and is utilized by primary care physicians, urologists, and oncologists. Armune BioScience operates through direct sales to healthcare providers and authorized representatives and has secured exclusive licensing of its technology from the University of Michigan, based on significant research published in reputable medical journals. As of December 2023, Armune operates as a subsidiary of Exact Sciences Corporation.
Sampleminded is a healthcare information technology company that specializes in providing customized software solutions for clinical trials and laboratories. The company focuses on developing laboratory and clinical information systems that facilitate laboratory management, clinical research services, and scientific data management. By offering software development, consulting services in bioinformatics, and system integration for biomedical devices, Sampleminded supports life sciences companies, diagnostics labs, research laboratories, and clinical trial organizations in managing critical specimens and test results. Its tools are designed to align with customers' objectives, promoting effective collaboration and partnership in the healthcare sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.